Alnylam Pharmaceuticals, Inc. (ALNY)
395.95
-3.45
(-0.86%)
USD |
NASDAQ |
Jan 09, 14:22
Alnylam Pharmaceuticals Accounts Payable (Quarterly): 117.59M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Biogen, Inc. | 413.10M |
| Insmed, Inc. | 79.59M |
| Pfizer Inc. | 5.024B |
| Bristol Myers Squibb Co. | 4.288B |
| BridgeBio Pharma, Inc. | 18.70M |